cover image: CADTH Reimbursement Review Foslevodopa- Foscarbidopa (Vyalev) - Sponsor: AbbVie Corporation Therapeutic area: Parkinson disease

20.500.12592/r16vhg

CADTH Reimbursement Review Foslevodopa- Foscarbidopa (Vyalev) - Sponsor: AbbVie Corporation Therapeutic area: Parkinson disease

13 Sep 2023

Tables

All